Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maaike Boonstra

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Autoimmunity Reviews|June 3, 2017
Auto-antibodies and cancer in systemic sclerosisMaaike Boonstra, Tom W J Huizinga, Jeska K de Vries-Bouwstra
Musculoskeletal Care|January 28, 2020
Illness perceptions, risk perceptions and worries in patients with early systemic sclerosis: A focus group studyNina M van Leeuwen, Maaike Boonstra, Tom W J Huizinga, et al.
Rheumatology (Oxford, England)|January 29, 2019
Prognostic properties of anti-topoisomerase antibodies in patients identified by the ACR/EULAR 2013 systemic sclerosis criteriaMaaike Boonstra, Maarten K Ninaber, Nina Ajmone Marsan, et al.
The Journal of Rheumatology|July 3, 2019
Degree of Vasculopathy in Systemic Sclerosis Patients with Anti-U3RNP Antibody Indicates Need for Extensive Cardiopulmonary ScreeningNina M VAN Leeuwen, Maaike Boonstra, Nina Ajmone Marsan, et al.
Arthritis Care & Research|September 22, 2020
Evolution of Systemic Sclerosis-Associated Interstitial Lung Disease One Year After Hematopoietic Stem Cell Transplantation or CyclophosphamideJacopo Ciaffi, Nina M van Leeuwen, Maaike Boonstra, et al.
Rheumatology (Oxford, England)|March 3, 2022
Gastrointestinal symptom severity and progression in systemic sclerosisNina M van Leeuwen, Maaike Boonstra, Håvard Fretheim, et al.
JACC. Cardiovascular Imaging|July 22, 2019
Clinical and Echocardiographic Associates of All-Cause Mortality and Cardiovascular Outcomes in Patients With Systemic SclerosisSuzanne E van Wijngaarden, Maaike Boonstra, Bas Bloem, et al.
RMD Open|July 28, 2023
Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosisCorrie M Wortel, Sophie Ie Liem, Nina M van Leeuwen, et al.
RMD Open|September 8, 2017
Rituximab in early systemic sclerosisMaaike Boonstra, Jessica Meijs, Annemarie L Dorjée, et al.
Clinical and Experimental Rheumatology|August 28, 2018
To what extent do autoantibodies help to identify high-risk patients in systemic sclerosis?Maaike Boonstra, Bart J A Mertens, Jaap A Bakker, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Autoimmunity Reviews|June 3, 2017
Auto-antibodies and cancer in systemic sclerosisMaaike Boonstra, Tom W J Huizinga, Jeska K de Vries-Bouwstra
Musculoskeletal Care|January 28, 2020
Illness perceptions, risk perceptions and worries in patients with early systemic sclerosis: A focus group studyNina M van Leeuwen, Maaike Boonstra, Tom W J Huizinga, et al.
Rheumatology (Oxford, England)|January 29, 2019
Prognostic properties of anti-topoisomerase antibodies in patients identified by the ACR/EULAR 2013 systemic sclerosis criteriaMaaike Boonstra, Maarten K Ninaber, Nina Ajmone Marsan, et al.
The Journal of Rheumatology|July 3, 2019
Degree of Vasculopathy in Systemic Sclerosis Patients with Anti-U3RNP Antibody Indicates Need for Extensive Cardiopulmonary ScreeningNina M VAN Leeuwen, Maaike Boonstra, Nina Ajmone Marsan, et al.
Arthritis Care & Research|September 22, 2020
Evolution of Systemic Sclerosis-Associated Interstitial Lung Disease One Year After Hematopoietic Stem Cell Transplantation or CyclophosphamideJacopo Ciaffi, Nina M van Leeuwen, Maaike Boonstra, et al.
Rheumatology (Oxford, England)|March 3, 2022
Gastrointestinal symptom severity and progression in systemic sclerosisNina M van Leeuwen, Maaike Boonstra, Håvard Fretheim, et al.
JACC. Cardiovascular Imaging|July 22, 2019
Clinical and Echocardiographic Associates of All-Cause Mortality and Cardiovascular Outcomes in Patients With Systemic SclerosisSuzanne E van Wijngaarden, Maaike Boonstra, Bas Bloem, et al.
RMD Open|July 28, 2023
Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosisCorrie M Wortel, Sophie Ie Liem, Nina M van Leeuwen, et al.
RMD Open|September 8, 2017
Rituximab in early systemic sclerosisMaaike Boonstra, Jessica Meijs, Annemarie L Dorjée, et al.
Clinical and Experimental Rheumatology|August 28, 2018
To what extent do autoantibodies help to identify high-risk patients in systemic sclerosis?Maaike Boonstra, Bart J A Mertens, Jaap A Bakker, et al.
Pageof 2